Since I’ve been living with psoriasis for over 15 years, you’d think I’d have this disease figured out by now. But when you live with a chronic disease, there will always be curveballs.

8% of patients maintained that the ongoing war had affected the quality of the treatment they are receiving for psoriasis.

The patches can also be more widespread on black skin making it harder to distinguish psoriasis from other conditions. However, a cream medication that eases skin inflammation might offer a safer ...

The prevalence of nail psoriasis (NP) ranges from 10% to 82% among patients ... had had a diagnosis of NP for more than one year. Previous treatments included topical corticosteroids and oral biotin.

Because psoriasis is a lifelong disease, many patients go in and out of treatment; a Markov analysis might be more appropriate to study such treatment, but we know of no studies that examined ...

Objectives: In this study, the authors evaluated the effectiveness and safety of two of these over a 52-week treatment period. Real-life studies are crucial for verifying the efficacy and safety of ...

Topical treatments, such as ointments and creams, are often the first-line treatment for people with psoriasis, according to the National Psoriasis Foundation (NPF). As psoriasis progresses or ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. By week 8, patients treated with roflumilast saw ...

The ultimate goal is to enhance patient care and treatment outcomes for genital psoriasis through informed decision-making and consistent clinical practices. Arcutis hosted the Genital Psoriasis ...

Positioned as the Dead Sea weight loss secret, ProZenith focuses on helping individuals overcome leptin resistance, a key hormonal barrier to long-term weight control. With ingredients like ...

Patients with type 2 diabetes (T2D) who have psoriasis showed an increased risk ... while CKD risk had increased at 10 years after starting treatment among those receiving biologics.